We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Alternative Therapy for Ear Infections

By HospiMedica staff writers
Posted on 05 Sep 2000
A panel of pediatricians and otolaryngologists from the American Academy of Pediatrics has determined that a topical antibiotic is an acceptable alternative to oral antibiotics for treating children with ear tubes who develop ear infections. More...
The findings of the panel, which met in Boston (MA, USA), are to be published in a future issue of the Pediatric Infectious Disease Journal.

The traditional treatment for children with middle ear infections is oral antibiotics. However, the incidence of antibiotic resistance is increasing. As the use of oral antibiotics grows, so does the incidence of resistance. Doctors place ear tubes in many children who have recurring infections to deter infection, but some children still become infected. Middle ear infections and drainage in these children can be treated with Floxin (ofloxacin otic solution, 0.3%), atopical antibiotic, said the panel.

"A topical antibiotic can be the first-line treatment of choice when treating ear drainage and infected ear tubes, if there is no underlying systemic infection,” stated panelist Seth Pransky, M.D., director, pediatric otolaryngology at Children's Hospital, San Diego, CA, USA.

Floxin has been cleared by the U.S. Food and Drug Administration (FDA) for otitis externa in patients aged one year or older (due to Pseudomonas aeruginosa and Staphylococcus aureus), acute otitis media in pediatric patients aged one year or older with tympanostomy tubes (due to P aeruginosa, S aureus, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae), and chronic suppurative otitis media in patients 12 years or older with perforated tympanic membranes (due to P aeruginosa, S aureus, or Proteus mirabilis). Floxin is the product of Daiichi Pharmaceutical Corp. (Tokyo, Japan).

Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Pediatric Mask
Respire SOFT
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Brain-Computer Interface Enables Responses in Some Unresponsive ICU Patients

Cognitive motor dissociation occurs when patients retain signs of consciousness but cannot move or speak to communicate. In the ICU, this hidden consciousness can be difficult to distinguish from coma... Read more

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.